$XGN
EXAGEN INC.

2020 Q4 Form 10-Q Financial Statement

#000127473720000097 Filed on November 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $12.67M $0.00 $10.44M
YoY Change 24.09% -100.0% 26.95%
Cost Of Revenue $4.340M $4.341M $400.0K
YoY Change -5.45% 985.25% -89.62%
Gross Profit $8.330M -$4.341M $10.04M
YoY Change 48.22% -143.24% 129.67%
Gross Profit Margin 65.75% 96.17%
Selling, General & Admin $9.930M $9.202M $7.306M
YoY Change 25.38% 25.95% 48.13%
% of Gross Profit 119.21% 72.78%
Research & Development $1.170M $1.018M $507.0K
YoY Change 105.26% 100.79% -3.43%
% of Gross Profit 14.05% 5.05%
Depreciation & Amortization $160.0K $100.0K $100.0K
YoY Change 45.45% 0.0% -50.0%
% of Gross Profit 1.92% 1.0%
Operating Expenses $11.09M $10.22M $7.813M
YoY Change 30.78% 30.81% 43.17%
Operating Profit -$2.760M -$3.786M -$2.157M
YoY Change -3.5% 75.52% 90.38%
Interest Expense -$650.0K $647.0K $909.0K
YoY Change -15.58% -28.82% 29.12%
% of Operating Profit
Other Income/Expense, Net $0.00 $125.0K $125.0K
YoY Change -100.0% 0.0% 380.77%
Pretax Income -$3.410M -$4.310M -$3.140M
YoY Change 0.89% 37.26% 78.41%
Income Tax $40.00K $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.450M -$4.308M -$3.141M
YoY Change 1.17% 37.15% 78.87%
Net Earnings / Revenue -27.23% -30.09%
Basic Earnings Per Share -$0.34
Diluted Earnings Per Share -$272.7K -$0.34 -$271.2K
COMMON SHARES
Basic Shares Outstanding 12.65M shares 12.64M shares
Diluted Shares Outstanding 12.64M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.40M $61.40M $77.80M
YoY Change -20.39% -21.08%
Cash & Equivalents $57.45M $61.43M $77.83M
Short-Term Investments
Other Short-Term Assets $1.203M $841.0K $916.0K
YoY Change -15.7% -8.19%
Inventory
Prepaid Expenses
Receivables $8.910M $9.297M $6.238M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $70.52M $72.56M $85.75M
YoY Change -13.21% -15.39%
LONG-TERM ASSETS
Property, Plant & Equipment $2.102M $1.758M $1.314M
YoY Change 52.32% 33.79%
Goodwill $5.506M $5.506M $5.506M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $250.0K $174.0K $172.0K
YoY Change 43.68% 1.16%
Total Long-Term Assets $7.858M $7.438M $6.992M
YoY Change 11.3% 6.38%
TOTAL ASSETS
Total Short-Term Assets $70.52M $72.56M $85.75M
Total Long-Term Assets $7.858M $7.438M $6.992M
Total Assets $78.38M $79.99M $92.74M
YoY Change -11.25% -13.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.014M $2.454M $1.213M
YoY Change 104.2% 102.31%
Accrued Expenses $5.757M $5.820M $6.449M
YoY Change 30.28% -9.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $300.0K
YoY Change
Total Short-Term Liabilities $8.771M $8.274M $7.662M
YoY Change 48.79% 7.99%
LONG-TERM LIABILITIES
Long-Term Debt $26.66M $26.45M $25.68M
YoY Change 3.11% 3.02%
Other Long-Term Liabilities $948.0K $645.0K $510.0K
YoY Change 48.59% 26.47%
Total Long-Term Liabilities $27.61M $27.10M $26.19M
YoY Change 4.21% 3.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.771M $8.274M $7.662M
Total Long-Term Liabilities $27.61M $27.10M $26.19M
Total Liabilities $36.54M $35.52M $34.09M
YoY Change 11.9% 4.18%
SHAREHOLDERS EQUITY
Retained Earnings -$181.3M -$177.8M -$161.2M
YoY Change 10.14% 10.3%
Common Stock $13.00K $13.00K $13.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.84M $44.47M $58.65M
YoY Change
Total Liabilities & Shareholders Equity $78.38M $79.99M $92.74M
YoY Change -11.25% -13.75%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$3.450M -$4.308M -$3.141M
YoY Change 1.17% 37.15% 78.87%
Depreciation, Depletion And Amortization $160.0K $100.0K $100.0K
YoY Change 45.45% 0.0% -50.0%
Cash From Operating Activities -$3.890M -$2.130M -$1.660M
YoY Change -1.02% 28.31% -17.82%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$210.0K $0.00
YoY Change -50.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K -$210.0K $0.00
YoY Change -50.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.00K 70.00K 63.26M
YoY Change -95.56% -99.89% -632700.0%
NET CHANGE
Cash From Operating Activities -3.890M -2.130M -1.660M
Cash From Investing Activities -10.00K -210.0K 0.000
Cash From Financing Activities -80.00K 70.00K 63.26M
Net Change In Cash -3.980M -2.270M 61.60M
YoY Change -30.78% -103.69% -5751.38%
FREE CASH FLOW
Cash From Operating Activities -$3.890M -$2.130M -$1.660M
Capital Expenditures -$10.00K -$210.0K $0.00
Free Cash Flow -$3.880M -$1.920M -$1.660M
YoY Change -0.77% 15.66% -15.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001274737
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39049
dei Entity Registrant Name
EntityRegistrantName
EXAGEN INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0434866
dei Entity Address Address Line1
EntityAddressAddressLine1
1261 Liberty Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Vista,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92081
dei City Area Code
CityAreaCode
(760)
dei Local Phone Number
LocalPhoneNumber
560-1501
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
XGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12652138 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61434000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72084000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9297000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5715000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1824000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3451000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
72555000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
81250000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1758000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1380000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
5506000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
5506000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000 USD
CY2020Q3 us-gaap Assets
Assets
79993000 USD
CY2019Q4 us-gaap Assets
Assets
88310000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2454000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1476000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5820000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4419000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8274000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5895000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26453000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25854000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
147000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
264000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
645000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
638000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
35519000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
32651000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12652113 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12652113 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12560990 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12560990 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
222297000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220248000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177836000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164602000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
44474000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55659000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79993000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88310000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10775000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10439000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29307000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30173000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4341000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4783000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12224000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14217000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9202000 USD
us-gaap Costs And Expenses
CostsAndExpenses
41731000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7306000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27104000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20787000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1018000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
507000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2403000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1610000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
14561000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
12596000 USD
us-gaap Costs And Expenses
CostsAndExpenses
36614000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3786000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2157000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12424000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6441000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
647000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
909000 USD
us-gaap Interest Expense
InterestExpense
1913000 USD
us-gaap Interest Expense
InterestExpense
2720000 USD
CY2020Q3 exdx Increase Decrease In Fair Value Of Financial Instruments
IncreaseDecreaseInFairValueOfFinancialInstruments
0 USD
CY2019Q3 exdx Increase Decrease In Fair Value Of Financial Instruments
IncreaseDecreaseInFairValueOfFinancialInstruments
-200000 USD
exdx Increase Decrease In Fair Value Of Financial Instruments
IncreaseDecreaseInFairValueOfFinancialInstruments
0 USD
exdx Increase Decrease In Fair Value Of Financial Instruments
IncreaseDecreaseInFairValueOfFinancialInstruments
267000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
125000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
125000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
985000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
264000 USD
CY2020Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-4308000 USD
CY2019Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-3141000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-13352000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-8630000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12626259 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
551730 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1513189 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4308000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3141000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13234000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8630000 USD
CY2020Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
338000 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
4640000 USD
CY2020Q3 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
CY2019Q3 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
13601000 USD
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
13601000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4308000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17080000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13234000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-26871000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-11.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-48.70
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12644348 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55659000 USD
CY2019Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
4100000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
431000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5563000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
50537000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
647000 USD
CY2020Q2 exdx Stock Issued During Period Value Warrants Exercised Net
StockIssuedDuringPeriodValueWarrantsExercisedNet
18000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3363000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
47841000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
142000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
799000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4308000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
44474000 USD
CY2018Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
532606084 shares
CY2018Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
105232000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-111966000 USD
CY2019Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2114000 USD
CY2019Q1 exdx Adjustments To Additional Paid In Capital Temporary Equity Accretion To Redemption Value
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityAccretionToRedemptionValue
2114000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12000 USD
CY2019Q1 exdx Temporary Equity Issued During The Period Shares Redeemable Convertible Preferred Stock
TemporaryEquityIssuedDuringThePeriodSharesRedeemableConvertiblePreferredStock
97646289 shares
CY2019Q1 exdx Temporary Equity Issued During The Period Value Redeemable Convertible Preferred Stock
TemporaryEquityIssuedDuringThePeriodValueRedeemableConvertiblePreferredStock
7520000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2704000 USD
CY2019Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
630252373 shares
CY2019Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
114866000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-116772000 USD
CY2019Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2188000 USD
CY2019Q2 exdx Adjustments To Additional Paid In Capital Temporary Equity Accretion To Redemption Value
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityAccretionToRedemptionValue
2188000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000 USD
CY2019Q2 exdx Temporary Equity Issued During The Period Shares Redeemable Convertible Preferred Stock
TemporaryEquityIssuedDuringThePeriodSharesRedeemableConvertiblePreferredStock
51282048 shares
CY2019Q2 exdx Temporary Equity Issued During The Period Value Redeemable Convertible Preferred Stock
TemporaryEquityIssuedDuringThePeriodValueRedeemableConvertiblePreferredStock
3972000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2785000 USD
CY2019Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
681534421 shares
CY2019Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
121026000 USD
us-gaap Advertising Expense
AdvertisingExpense
900000 USD
us-gaap Advertising Expense
AdvertisingExpense
1100000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-121734000 USD
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
338000 USD
CY2019Q3 exdx Adjustments To Additional Paid In Capital Temporary Equity Accretion To Redemption Value
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityAccretionToRedemptionValue
338000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000 USD
CY2019Q3 exdx Adjustments To Additional Paid In Capital Issuance Of Temporary Equity
AdjustmentsToAdditionalPaidInCapitalIssuanceOfTemporaryEquity
6741000 USD
CY2019Q3 exdx Temporary Equity Deemed Dividends With Beneficial Conversion Feature
TemporaryEquityDeemedDividendsWithBeneficialConversionFeature
6741000 USD
CY2019Q3 exdx Adjustments To Additional Paid In Capital Temporary Equity With Beneficial Conversion Feature
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityWithBeneficialConversionFeature
6741000 USD
CY2019Q3 exdx Temporary Equity Deemed Dividend Shares Issued
TemporaryEquityDeemedDividendSharesIssued
97592739 shares
CY2019Q3 exdx Temporary Equity Deemed Dividend
TemporaryEquityDeemedDividend
6860000 USD
CY2019Q3 exdx Adjustments To Additional Paid In Capital Temporary Equity Deemed Dividends
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityDeemedDividends
6860000 USD
CY2019Q3 exdx Temporary Equity Shares Redeemed Upon Conversion
TemporaryEquitySharesRedeemedUponConversion
1012573679 shares
CY2019Q3 exdx Temporary Equity Shares Redeemed Upon Conversion Amount
TemporaryEquitySharesRedeemedUponConversionAmount
138906000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
138906000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50518000 USD
CY2019Q3 exdx Stock Issued During Period Value Warrants Exercised Net
StockIssuedDuringPeriodValueWarrantsExercisedNet
511000 USD
CY2019Q3 exdx Adjustments To Additional Paid In Capital Reclassification Of Preferred Stock Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfPreferredStockWarrantLiability
726000 USD
CY2020Q3 exdx Purchase Obligation Annual Increase In Commitment Percentage
PurchaseObligationAnnualIncreaseInCommitmentPercentage
0.15
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
400000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3141000 USD
CY2019Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2019Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
58650000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13234000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8630000 USD
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
392000 USD
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
480000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
202000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
575000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
397000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
484000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-267000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-117000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-20000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1877000 USD
us-gaap Cost Of Revenue
CostOfRevenue
1100000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
85000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3582000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
286000 USD
exdx Increase Decrease In Prepaid Expense And Current Other Assets
IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets
-1627000 USD
exdx Increase Decrease In Prepaid Expense And Current Other Assets
IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets
-510000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
24000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
781000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
174000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1472000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1095000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10185000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5784000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
450000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
377000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-450000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
142000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
187000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
94000 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
2865000 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
2865000 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
52195000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70525000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10650000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64664000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72184000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13264000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61534000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77928000 USD
us-gaap Interest Paid Net
InterestPaidNet
1312000 USD
us-gaap Interest Paid Net
InterestPaidNet
1661000 USD
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0 USD
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4640000 USD
exdx Equipment Purchased Under Capital Lease
EquipmentPurchasedUnderCapitalLease
123000 USD
exdx Equipment Purchased Under Capital Lease
EquipmentPurchasedUnderCapitalLease
412000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
197000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
71000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
138906000 USD
exdx Noncash Exercise Of Stock Purchase Warrants
NoncashExerciseOfStockPurchaseWarrants
0 USD
exdx Noncash Exercise Of Stock Purchase Warrants
NoncashExerciseOfStockPurchaseWarrants
511000 USD
exdx Deferred Offering Costs Included Within Current Liabilities
DeferredOfferingCostsIncludedWithinCurrentLiabilities
0 USD
exdx Deferred Offering Costs Included Within Current Liabilities
DeferredOfferingCostsIncludedWithinCurrentLiabilities
1677000 USD
exdx Reclassification Of Temporary Equity And Liabilities To Permanent Equity
ReclassificationOfTemporaryEquityAndLiabilitiesToPermanentEquity
0 USD
exdx Reclassification Of Temporary Equity And Liabilities To Permanent Equity
ReclassificationOfTemporaryEquityAndLiabilitiesToPermanentEquity
726000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61400000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177800000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risk and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and accounts receivable. Substantially all the Company's cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits.</span></div>
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10775000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10439000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29307000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30173000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61434000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72084000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
100000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
100000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61534000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72184000 USD
CY2020Q3 exdx Joint Venture Quarterly Promotion Fee Capped Amount Percentage Above Baseline
JointVentureQuarterlyPromotionFeeCappedAmountPercentageAboveBaseline
0.05
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
300000 USD
CY2019Q3 us-gaap Advertising Expense
AdvertisingExpense
400000 USD
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2402077 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1936279 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2402077 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1936279 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
841000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1427000 USD
CY2020Q3 us-gaap Prepaid Royalties
PrepaidRoyalties
72000 USD
CY2019Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
123000 USD
CY2020Q3 exdx Prepaid Maintenance And Insurance Contracts
PrepaidMaintenanceAndInsuranceContracts
897000 USD
CY2019Q4 exdx Prepaid Maintenance And Insurance Contracts
PrepaidMaintenanceAndInsuranceContracts
1768000 USD
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
14000 USD
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
133000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1824000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3451000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4545000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3775000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2787000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2395000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1758000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1380000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
500000 USD
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3818000 USD
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2362000 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
142000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
145000 USD
CY2020Q3 exdx Accrued Purchase Goods And Services Current
AccruedPurchaseGoodsAndServicesCurrent
542000 USD
CY2019Q4 exdx Accrued Purchase Goods And Services Current
AccruedPurchaseGoodsAndServicesCurrent
319000 USD
CY2020Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
178000 USD
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
727000 USD
CY2020Q3 exdx Accrued Liabilities Clinical Study Current
AccruedLiabilitiesClinicalStudyCurrent
139000 USD
CY2019Q4 exdx Accrued Liabilities Clinical Study Current
AccruedLiabilitiesClinicalStudyCurrent
40000 USD
CY2020Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
272000 USD
CY2019Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
238000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
729000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
588000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5820000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4419000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
437000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1755000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2996000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
15619000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
14280000 USD
CY2020Q3 exdx Long Term Debt Including Undiscounted Interest
LongTermDebtIncludingUndiscountedInterest
35087000 USD
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
320000 USD
CY2020Q3 exdx Long Term Debt Undiscounted Interest Amount
LongTermDebtUndiscountedInterestAmount
8314000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
26453000 USD
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2019Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
500000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2019Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
6000000.0 USD
CY2019Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
2800000 USD
CY2019Q3 exdx Temporary Equity Deemed Dividend
TemporaryEquityDeemedDividend
6900000 USD
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
426827 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
32120 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1375542 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.33
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M28D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23654000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
901531 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.14
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
47354 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
244749 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9720 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.27
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
29.11
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1975250 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.77
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y11M8D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5064000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1975250 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.77
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y11M8D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5064000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
394739 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y3M
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2430000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.52
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.59
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.017
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.026
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Revenues
Revenues
700000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
799000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1877000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
9300000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2020Q3 exdx Avisectd Test Volume Percentage
AVISECTDTestVolumePercentage
0.04
exdx Avisectd Test Volume Percentage
AVISECTDTestVolumePercentage
0.08
CY2020Q1 exdx Coronavirus Aid Relief And Economic Securities Cares Act Deferred Tax Assets Valuation Allowance
CoronavirusAidReliefAndEconomicSecuritiesCARESActDeferredTaxAssetsValuationAllowance
100000 USD
CY2020Q1 exdx Coronavirus Aid Relief And Economic Securities Cares Act Deferred Tax Assets Income Tax Benefit
CoronavirusAidReliefAndEconomicSecuritiesCARESActDeferredTaxAssetsIncomeTaxBenefit
100000 USD
CY2020Q2 exdx Coronavirus Aid Relief And Economic Securities Cares Act Proceeds From Loan
CoronavirusAidReliefAndEconomicSecuritiesCARESActProceedsFromLoan
700000 USD
CY2020Q3 us-gaap Revenues
Revenues
0 USD
CY2020Q2 exdx Coronavirus Aid Relief And Economic Securities Cares Act Proceeds From Loan
CoronavirusAidReliefAndEconomicSecuritiesCARESActProceedsFromLoan
2900000 USD

Files In Submission

Name View Source Status
0001274737-20-000097-index-headers.html Edgar Link pending
0001274737-20-000097-index.html Edgar Link pending
0001274737-20-000097.txt Edgar Link pending
0001274737-20-000097-xbrl.zip Edgar Link pending
ex101-innovatusacknowl.htm Edgar Link pending
exdx-20200930.htm Edgar Link pending
exdx-20200930.xsd Edgar Link pending
exdx-20200930_cal.xml Edgar Link unprocessable
exdx-20200930_def.xml Edgar Link unprocessable
exdx-20200930_htm.xml Edgar Link completed
exdx-20200930_lab.xml Edgar Link unprocessable
exdx-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xgn311-93020.htm Edgar Link pending
xgn312-93020.htm Edgar Link pending
xgn321-93020.htm Edgar Link pending